EVI1 expression in acute myeloid leukaemia

British Journal of Haematology

Volumn 112, Issue 1, 2001, Pages 208-211

  Langabeer, S E ^a,g   Rogers, J R ^a   Harrison, G ^b   Wheatley, K ^c   Walker, H ^a   Bain, B J ^d   Burnett, A K ^e   Goldstone, A H ^a   Linch, D C ^a   Grimwade, D ^a,f  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b RADCLIFFE INFIRMARY   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^e CARDIFF UNIVERSITY   (United Kingdom)

^f GUY S HOSPITAL   (United Kingdom)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

3q26; AML; APL; Clinical trials; EVI1

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR EVI1; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CHROMOSOME 3Q; CHROMOSOME ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE EXPRESSION; GENETIC SCREENING; HUMAN; MAJOR CLINICAL STUDY; MEGAKARYOPOIESIS; PRIORITY JOURNAL; PROGNOSIS;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DNA-BINDING PROTEINS; FEMALE; HUMANS; KARYOTYPING; LEUKEMIA, MYELOID; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; MIDDLE AGED; PROTO-ONCOGENES; RISK FACTORS; TRANSCRIPTION FACTORS;

EID: 0035133157     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2001.02569.x     Document Type: Article

References (10)

1. Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid: Result of the randomized MRC trial
2. Human AML1/MDS1/ EVIl fusion protein induces an acute myelogenous leukemia (AML) in mice: A model for human AML
3. The importance of diagnostic cytogenetics on outcome in AML: Analysis of 1,612 patients entered into the MRC AML 10 trial
4. Incidence of AML1/ETO fusion transcripts in patients entered in to the MRC AML trials
5. The EVI1 gene in myeloid leukemia
6. Expression of EVIl in myelodysplastic syndromes and other hematologic malignancies without 3q26 translocations
7. Abnormalities of 3q21 and 3q26 in myeloid malignancy: A United Kingdom Cancer Cytogenetic Group study
8. Forced expression of the leukemia-associated gene EVI1 in ES cells: A model for myeloid leukemia with 3q26 rearrangements
9. Expression of the Zn finger gene, EVI-1, in acute promyelocytic leukemia